Aditi Shastri
Montefiore Medical Center
Built from public records under this name as ClinicalTrials.gov spells it. A name can belong to more than one person, so each section says how its rows were tied to this name. No contact details are shown.
Trials
Studies that name Aditi Shastri as principal investigator, study chair or study director, newest first. Live from ClinicalTrials.gov, fetched 2026-11-12 01:58 UTC. Open this list on ClinicalTrials.gov
- Ph1NCT05986240 · Danvatirsen Monotherapy Followed by Combination With Venetoclax in Relapsed/Refractory MDS & AMLMontefiore Medical Center · recruiting · AML/MDS, Acute Myeloid Leukemia, Myelodysplastic Syndromes · principal investigator
- Ph1NCT03057990 · Pyrimethamine for Intermediate/High-risk Myelodysplastic Syndromes (MDS)Montefiore Medical Center · withdrawn · Myelodysplastic Syndromes · principal investigator
Grants
NIH projects from RePORTER, fetched 2026-11-12 01:58 UTC. A project is listed only when its grant number is on one of the trials above, or when the awardee institution matches an affiliation the registry gives for this name. 4 other NIH projects list an investigator with the same name at a different institution and are left out. Coverage is US federal funding only; UK and EU funders are not searched yet.
No NIH project could be tied to this name by a shared trial or a matching institution.
Most cited trial papers
Clinical-trial papers with this author name, ranked by citations from NIH iCite, fetched 2026-11-12 01:58 UTC. The ranking covers the 200 most relevant of 12 PubMed records, and a shared surname and initials can bring in a namesake. All 12 on PubMed
- BOLD-f MRI response to single-pulse transcranial magnetic stimulation (TMS).J Magn Reson Imaging · 200093 citationsRCR 2.7
- 90 citationsRCR 12.0
- Clinical Trials Assessing Hypomethylating Agents Combined with Other Therapies: Causes for Failure and Potential Solutions.Clin Cancer Res · 202135 citationsRCR 1.8
- Phase II study of pomalidomide in combination with prednisone in patients with myelofibrosis and significant anemia.Leuk Res · 201428 citationsRCR 0.9
- Modest activity of pomalidomide in patients with myelofibrosis and significant anemia.Leuk Res · 201321 citationsRCR 0.7
- 19 citationsRCR 3.9
- Prefrontal cortex transcranial magnetic stimulation does not change local diffusion: a magnetic resonance imaging study in patients with depression.Cogn Behav Neurol · 200316 citationsRCR 0.5
- 15 citationsRCR 1.8
- Lenalidomide and Eltrombopag for Treatment of Low- or Intermediate-Risk Myelodysplastic Syndrome: Result of a Phase II Clinical Trial.Clin Cancer Res · 20239 citationsRCR 1.0
- Barriers to the management of sexual dysfunction among people with psychosis: analysis of qualitative data from the REMEDY trial.BMC Psychiatry · 20227 citationsRCR 0.8